Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
EKF Diagnostics to Premier Novel Diagnostic Tests at Medica 2013
Friday, November 08, 2013
Visit Medica 2013, Hall 3 Stand C70.

Quotient Clinical at AAPS 2013
Friday, November 08, 2013
AAPS annual meeting and exposition to be held in San Antonio, Texas, from the 10th to the 14th of November.

First VolitionRx Study Data Presented at CNAPS
Thursday, November 07, 2013
Initial study results demonstrate detection rate of 75% for colorectal cancer.

iTAPP Declares Radiometer’s AQT90 FLEX a ‘High Impact Innovation’
Wednesday, November 06, 2013
AQT90 FLEX analyzer’s advanced technology allows rapid, laboratory standard testing.

Ventana Launches VENTANA Gram Staining Kit
Monday, October 28, 2013
Fully automated Gram stain on the benchmark special stains platform.

Identifying Suspicious Skin Lesions with a Noninvasive, Painless Device
Monday, October 28, 2013
VivaScope®cellular imaging devices from Caliber Imaging & Diagnostics.

Evaluation Success for EKF’s POCT HbA1c Analyzers
Wednesday, October 23, 2013
Quo-Test and Quo-Lab analyzers meet set requirements for determination of HbA1c.

BIOTRONIK Celebrates 50th Anniversary at Heart Rhythm Congress 2013
Monday, October 21, 2013
Company showcase a number of new innovations.

New ‘Supermix’ Controls Totally Streamline QC in Medical Laboratories
Tuesday, October 15, 2013
Randox has launched two new liquid assayed chemistry controls, which save time and money whilst ensuring highly accurate results and patient diagnosis.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 438
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv